Literature DB >> 30720873

Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults.

Jolien Schaeverbeke1,2, Benjamin Gille3,4, Katarzyna Adamczuk1,2,5, Hugo Vanderstichele6, Emeric Chassaing6, Rose Bruffaerts1,7, Veerle Neyens1,2, Erik Stoops6, Jos Tournoy2,4,8, Rik Vandenberghe1,2,7, Koen Poesen3,4,9.   

Abstract

The main pathophysiological alterations of Alzheimer's disease (AD) include loss of neuronal and synaptic integrity, amyloidogenic processing, and neuroinflammation. Similar alterations can, however, also be observed in cognitively intact older subjects and may prelude the clinical manifestation of AD. The objectives of this prospective cross-sectional study in a cohort of 38 cognitively intact older adults were twofold: (i) to investigate the latent relationship among cerebrospinal fluid (CSF) biomarkers reflecting the main pathophysiological processes of AD, and (ii) to assess the correlation between these biomarkers and gray matter volume as well as amyloid load. All subjects underwent extensive neuropsychological examinations, CSF sampling, [18 F]-flutemetamol amyloid positron emission tomography, and T1 -weighted magnetic resonance imaging. A factor analysis revealed one factor that explained most of the variance in the CSF biomarker dataset clustering t-tau, α-synuclein, p-tau181 , neurogranin, BACE1, visinin-like protein 1, chitinase-3-like protein 1 (YKL-40), Aβ1-40 and Aβ1-38 . Higher scores on this factor correlated with lower gray matter volume and with higher amyloid load in the precuneus. At the level of individual CSF biomarkers, levels of visinin-like protein 1, neurogranin, BACE1, Aβ1-40 , Aβ1-38, and YKL-40 all correlated inversely with gray matter volume of the precuneus. These findings demonstrate that in cognitively intact older subjects, CSF levels of synaptic and neuronal integrity biomarkers, amyloidogenic processing and measures of innate immunity (YKL-40) display a latent structure of common variance, which is associated with loss of structural integrity of brain regions implicated in the earliest stages of AD. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript, and for *Preregistration* because the study was pre-registered at https://osf.io/7qm9t/. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; BACE1; VILIP-1; cerebrospinal fluid biomarkers; neurogranin; precuneus

Mesh:

Substances:

Year:  2019        PMID: 30720873     DOI: 10.1111/jnc.14680

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration.

Authors:  Jeffrey L Brabec; Montana Kay Lara; Anna L Tyler; J Matthew Mahoney
Journal:  Front Genet       Date:  2021-04-06       Impact factor: 4.599

2.  Serum neurofilament heavy chains as early marker of motor neuron degeneration.

Authors:  Maxim De Schaepdryver; Janne Goossens; Steffi De Meyer; Andreas Jeromin; Pegah Masrori; Britta Brix; Kristl G Claeys; Jolien Schaeverbeke; Katarzyna Adamczuk; Rik Vandenberghe; Philip Van Damme; Koen Poesen
Journal:  Ann Clin Transl Neurol       Date:  2019-09-13       Impact factor: 4.511

3.  Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease.

Authors:  Douglas Galasko; Meifang Xiao; Desheng Xu; Denis Smirnov; David P Salmon; Nele Dewit; Jeroen Vanbrabant; Dirk Jacobs; Hugo Vanderstichele; Eugeen Vanmechelen; Paul Worley
Journal:  Alzheimers Dement (N Y)       Date:  2019-12-09

Review 4.  β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.

Authors:  Harald Hampel; Simone Lista; Eugeen Vanmechelen; Henrik Zetterberg; Filippo Sean Giorgi; Alessandro Galgani; Kaj Blennow; Filippo Caraci; Brati Das; Riqiang Yan; Andrea Vergallo
Journal:  Alzheimers Res Ther       Date:  2020-10-16       Impact factor: 6.982

5.  Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults.

Authors:  Jolien M Schaeverbeke; Silvy Gabel; Karen Meersmans; Emma S Luckett; Steffi De Meyer; Katarzyna Adamczuk; Natalie Nelissen; Valerie Goovaerts; Ahmed Radwan; Stefan Sunaert; Patrick Dupont; Koen Van Laere; Rik Vandenberghe
Journal:  Alzheimers Res Ther       Date:  2021-04-07       Impact factor: 6.982

Review 6.  Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer's Disease.

Authors:  Bin Zhou; Masanori Fukushima
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.